295 related articles for article (PubMed ID: 10469631)
21. The effects of dietary flaxseed on the Fischer 344 rat: II. Liver gamma-glutamyltranspeptidase activity.
Hemmings SJ; Westcott N; Muir A; Czechowicz D
Cell Biochem Funct; 2004; 22(4):225-31. PubMed ID: 15248182
[TBL] [Abstract][Full Text] [Related]
22. Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: Engagement of antioxidant mechanism.
Hu P; Mei QY; Ma L; Cui WG; Zhou WH; Zhou DS; Zhao Q; Xu DY; Zhao X; Lu Q; Hu ZY
Eur J Pharmacol; 2015 Nov; 767():183-92. PubMed ID: 26494631
[TBL] [Abstract][Full Text] [Related]
23. Flaxseed and lignans increase cecal beta-glucuronidase activity in rats.
Jenab M; Rickard SE; Orcheson LJ; Thompson LU
Nutr Cancer; 1999; 33(2):154-8. PubMed ID: 10368810
[TBL] [Abstract][Full Text] [Related]
24. Protective Role of Flaxseed Oil and Flaxseed Lignan Secoisolariciresinol Diglucoside Against Oxidative Stress in Rats with Metabolic Syndrome.
Pilar B; Güllich A; Oliveira P; Ströher D; Piccoli J; Manfredini V
J Food Sci; 2017 Dec; 82(12):3029-3036. PubMed ID: 29083494
[TBL] [Abstract][Full Text] [Related]
25. Maternal exposure to an n-3 polyunsaturated fatty acid diet decreases mammary cancer risk of female offspring in adulthood.
Li J; Li K; Gao J; Guo X; Lu M; Li Z; Li D
Food Funct; 2018 Nov; 9(11):5768-5777. PubMed ID: 30327803
[TBL] [Abstract][Full Text] [Related]
26. Discriminatory and cooperative effects within the mouse gut microbiota in response to flaxseed and its oil and lignan components.
Taibi A; Ku M; Lin Z; Gargari G; Kubant A; Lepp D; Power KA; Guglielmetti S; Thompson LU; Comelli EM
J Nutr Biochem; 2021 Dec; 98():108818. PubMed ID: 34271098
[TBL] [Abstract][Full Text] [Related]
27. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis.
Russo IH; Koszalka M; Russo J
Carcinogenesis; 1990 Oct; 11(10):1849-55. PubMed ID: 2119909
[TBL] [Abstract][Full Text] [Related]
28. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.
Saggar JK; Chen J; Corey P; Thompson LU
Mol Nutr Food Res; 2010 Mar; 54(3):415-25. PubMed ID: 19904759
[TBL] [Abstract][Full Text] [Related]
29. The legitimacy of using dietary supplement diglycoside secoisolariciresinol (SDG) from flaxseed in cancer.
Dobrowolska K; Regulska-Ilow B
Rocz Panstw Zakl Hig; 2021; 72(1):9-20. PubMed ID: 33882661
[TBL] [Abstract][Full Text] [Related]
30. Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats.
Ward WE; Yuan YV; Cheung AM; Thompson LU
Br J Nutr; 2001 Oct; 86(4):499-505. PubMed ID: 11591237
[TBL] [Abstract][Full Text] [Related]
31. Exposure to flaxseed and its purified lignan reduces bone strength in young but not older male rats.
Ward WE; Yuan YV; Cheung AM; Thompson LU
J Toxicol Environ Health A; 2001 May; 63(1):53-65. PubMed ID: 11346133
[TBL] [Abstract][Full Text] [Related]
32. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis.
Cabanes A; Wang M; Olivo S; DeAssis S; Gustafsson JA; Khan G; Hilakivi-Clarke L
Carcinogenesis; 2004 May; 25(5):741-8. PubMed ID: 14729590
[TBL] [Abstract][Full Text] [Related]
33. Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats.
Mukker JK; Singh RS; Muir AD; Krol ES; Alcorn J
Br J Nutr; 2015 Mar; 113(5):749-57. PubMed ID: 25716060
[TBL] [Abstract][Full Text] [Related]
34. Toward a physiological approach to breast cancer prevention.
Russo J; Russo IH
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):353-64. PubMed ID: 8061586
[TBL] [Abstract][Full Text] [Related]
35. Antitumorigenic effect of a mammalian lignan precursor from flaxseed.
Thompson LU; Seidl MM; Rickard SE; Orcheson LJ; Fong HH
Nutr Cancer; 1996; 26(2):159-65. PubMed ID: 8875553
[TBL] [Abstract][Full Text] [Related]
36. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone.
Kitts DD; Yuan YV; Wijewickreme AN; Thompson LU
Mol Cell Biochem; 1999 Dec; 202(1-2):91-100. PubMed ID: 10705999
[TBL] [Abstract][Full Text] [Related]
37. The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth.
Bowers LW; Lineberger CG; Ford NA; Rossi EL; Punjala A; Camp KK; Kimler BK; Fabian CJ; Hursting SD
Breast Cancer Res Treat; 2019 Feb; 173(3):545-557. PubMed ID: 30367332
[TBL] [Abstract][Full Text] [Related]
38. Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.
Russo IH; Frederick J; Russo J
Breast Cancer Res Treat; 1989 Oct; 14(1):43-56. PubMed ID: 2513893
[TBL] [Abstract][Full Text] [Related]
39. Urinary composition and postprandial blood changes in H-secoisolariciresinol diglycoside (SDG) metabolites in rats do not differ between acute and chronic SDG treatments.
Rickard SE; Thompson LU
J Nutr; 2000 Sep; 130(9):2299-305. PubMed ID: 10958827
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence.
Russo J; Russo IH
Am J Pathol; 1980 Aug; 100(2):497-512. PubMed ID: 6773421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
